Schonfeld Strategic Advisors’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
50,964
+15,258
| +43% | +$1.28M | 0.03% | 552 |
|
|
2025
Q1 | $2.55M | Buy |
+35,706
| New | +$2.55M | 0.02% | 740 |
|
|
2024
Q4 | – | Sell |
-54,273
| Closed | -$2.74M | – | 2209 |
|
|
2024
Q3 | $2.74M | Buy |
54,273
+254
| +0.5% | +$12.8K | 0.02% | 642 |
|
|
2024
Q2 | $2.2M | Buy |
54,019
+8,547
| +19% | +$349K | 0.01% | 759 |
|
|
2024
Q1 | $1.95M | Sell |
45,472
-15,418
| -25% | -$660K | 0.01% | 846 |
|
|
2023
Q4 | $2.45M | Buy |
60,890
+37,690
| +162% | +$1.52M | 0.02% | 675 |
|
|
2023
Q3 | $685K | Buy |
+23,200
| New | +$685K | 0.01% | 1009 |
|
|
2021
Q1 | – | Sell |
-1,253
| Closed | -$36K | – | 2034 |
|
|
2020
Q4 | $36K | Sell |
1,253
-1,374
| -52% | -$39.5K | ﹤0.01% | 1471 |
|
|
2020
Q3 | $98K | Buy |
+2,627
| New | +$98K | ﹤0.01% | 1235 |
|